Search

Search Constraints

You searched for: Author/Creator Millward, Michael

Search Results

43. Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy. Issue 2 (23rd November 2020)

44. Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy. Issue 2 (23rd November 2020)

45. Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy. Issue 2 (23rd November 2020)

46. Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy. Issue 2 (23rd November 2020)

47. Real‐world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma. Issue 1 (13th November 2018)

48. Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma. Issue 1 (20th April 2020)

49. Safety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancer. (2021)

50. Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in Australia. Issue 8 (August 2017)